Wall Street
Jeff Yass: The Billionaire Trader Shaping Politics and Finance
Jeff Yass is one of the most influential figures in modern American finance and politics, yet he remains relatively unknown outside elite circles....
Ken Griffin: The Visionary Behind Citadel’s Rise
Ken Griffin is a name that resonates across financial markets, philanthropy, and business innovation. As the founder and CEO of Citadel, one of...
Michael Bloomberg: A Life of Business, Politics, and Philanthropy
Michael Bloomberg is a name that resonates across the worlds of business, politics, and philanthropy. Born on February 14, 1942, in Boston, Massachusetts,...
Bitcoin Shatters Records, Surges Past $109,000 as Trump’s Inauguration Fuels Crypto Rally
In a historic moment for the cryptocurrency market, Bitcoin reached an unprecedented all-time high of $109,356 on Monday, January 20, 2025, just hours...
Hindenburg Research Shuts Down: The End of a Controversial Wall Street Watchdog
In a surprising announcement that sent ripples through the financial world, Nate Anderson, founder of the influential short-selling firm Hindenburg Research, declared the...
Peter Kellogg: Wall Street Titan’s Latest Ventures and Board Appointments in 2025
Peter R. Kellogg, the billionaire Wall Street veteran with an estimated net worth of $4.7 billion as of January 2025, continues to make...
The Billionaire Philanthropist: Daniel D’Aniello’s Recent Moves and Lasting Legacy
Daniel A. D’Aniello, co-founder and Chairman Emeritus of the Carlyle Group, continues to make significant moves in both business and philanthropy as of...
Macquarie’s $5B Investment Propels Applied Digital Stock to New Heights Amid AI Infrastructure Expansion
Applied Digital (NASDAQ: APLD) experienced a remarkable surge of 25% in its stock price today following the announcement of a groundbreaking $5 billion...
Trump Media Stock Surges 21% Ahead of Presidential Inauguration as Tech Giants Back Trump’s Return
Trump Media & Technology Group (DJT) shares experienced a remarkable surge of over 21% in recent trading, marking its strongest performance since November...
Johnson & Johnson Acquires Intra-Cellular Therapies for $14.6 Billion, Expanding Mental Health Portfolio
In a significant move that reshapes the landscape of mental health therapeutics, Johnson & Johnson (NYSE: JNJ) announced today its acquisition of Intra-Cellular...
